Michael Kirban - 14 Sep 2023 Form 4 Insider Report for Vita Coco Company, Inc. (COCO)

Role
Executive Chairman, Director
Signature
By: Yolanda Goettsch, Attorney-in-Fact For: Michael Kirban
Issuer symbol
COCO
Transactions as of
14 Sep 2023
Net transactions value
-$1,735,437
Form type
4
Filing time
18 Sep 2023, 18:49:58 UTC
Previous filing
14 Mar 2023
Next filing
20 Dec 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction COCO Common Stock Sale $1,340,531 -45,302 -5.7% $29.59 750,379 14 Sep 2023 by M. Kirban Revoc F1, F2, F3
transaction COCO Common Stock Sale $394,906 -14,698 -2% $26.87 735,681 15 Sep 2023 by M. Kirban Revoc F1, F3, F4
holding COCO Common Stock 61,307 14 Sep 2023 Direct
holding COCO Common Stock 2,026,229 14 Sep 2023 by M. Kirban 2010 F5

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding COCO Non-Qualified Stock Option (right to buy) 546,000 14 Sep 2023 Common Stock 546,000 $10.18 Direct F6
holding COCO Non-Qualified Stock Option (right to buy) 40,950 14 Sep 2023 Common Stock 40,950 $10.18 Direct F7
holding COCO Non-Qualified Stock Option (right to buy) 298,507 14 Sep 2023 Common Stock 298,507 $15.00 Direct F8
holding COCO Non-Qualified Stock Option (right to buy) 46,875 14 Sep 2023 Common Stock 46,875 $16.91 Direct F9
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.

Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Explanation of Responses:

Id Content
F1 The sales of shares of common stock reported were effected pursuant to a Rule 10b5-1 trading plan.
F2 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $28.42 to $31.90, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
F3 These shares are held by the Michael Kirban Revocable Trust.
F4 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $25.95 to $29.06, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
F5 These shares are held by the Michael Kirban 2010 Trust.
F6 The stock option is fully vested and currently exercisable.
F7 The stock option vests in two equal installments on January 11, 2023 and January 11, 2025.
F8 The stock option vests in four equal annual installments beginning on November 27, 2022.
F9 The stock options vest in four annual equal installments beginning on March 10, 2024.